Avantor® closes previously announced divestiture of its clinical services business

Radnor, pa. , oct. 18, 2024 /prnewswire/ -- avantor, inc. (nyse: avtr), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to audax private equity in a transaction valued at approximately $650 million.
AVTR Ratings Summary
AVTR Quant Ranking